Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer

Published:2023-09 Issue: Volume:391-392 Page:104760
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Wang Aying^ORCID,Lv Tangfeng,Song Yong

Publisher

Elsevier BV

Subject

Immunology

Reference41 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Deep-LC: A novel deep learning method of identifying non-small cell lung cancer-related genes;Li;Front. Oncol.,2022

3. Myeloid-derived suppressor cell heterogeneity in human cancers;Solito;Ann. N. Y. Acad. Sci.,2014

4. Current progress in CAR-T cell therapy for hematological malignancies;Han;J. Cancer,2021

5. CAR T cell immunotherapy for human cancer;June;Science,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The next frontier in immunotherapy: potential and challenges of CAR-macrophages;Experimental Hematology & Oncology;2024-08-05

2. CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects;Frontiers in Immunology;2024-07-18

3. Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023);Human Vaccines & Immunotherapeutics;2024-05-02

4. Significance of PSCA as a novel prognostic marker and therapeutic target for cancer;Cancer Cell International;2024-04-16

5. CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies;Frontiers in Immunology;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3